List of Health2Sync Patient Management Platform Customers
Health2Sync
4f no. 32 Alley 18 Lane 478, Ruiguang Road,
Taipei, 114,
Taiwan
Taipei, 114,
Taiwan
886 287976661
Professional Services
50
$5M
Since 2010, our global team of researchers has been studying Health2Sync Patient Management Platform customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Health2Sync Patient Management Platform for Patient Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Health2Sync Patient Management Platform for Patient Management include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Sompo Holdings, a Japan based Insurance organisation with 80000 employees and revenues of $35.91 billion, Sanofi KK Japan, a Japan based Life Sciences organisation with 1341 employees and revenues of $1.43 billion, Novo Nordisk Japan, a Japan based Life Sciences organisation with 1068 employees and revenues of $83.3 million and many others.
Contact us if you need a completed and verified list of companies using Health2Sync Patient Management Platform, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Health2Sync Patient Management Platform customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | Health2Sync | Health2Sync Patient Management Platform | Patient Management | 2022 | n/a |
In 2022, AstraZeneca Taiwan signed an MOU with Health2Sync to deploy the Health2Sync Patient Management Platform for early detection and digital management of chronic kidney disease across Taiwanese providers. The engagement positions AstraZeneca to use the Health2Sync Patient Management Platform within clinical care and chronic disease management programs, with explicit focus on screening and longitudinal patient monitoring under the Patient Management category.
The implementation centers on Health2Sync Patient Management Platform capabilities for chronic kidney disease, including inferred usage of CKD risk detection and patient monitoring features described in the announcement. The platform configuration emphasizes automated filtering and categorization of laboratory results to surface at-risk patients, combined with risk stratification and patient follow up workflows to enable earlier clinical intervention consistent with Patient Management functional patterns.
Operational coverage is scoped to Taiwanese provider networks with program governance led by AstraZeneca Taiwan and Health2Sync, targeting clinical care teams, nephrology services, and population health management functions. Integration work includes connecting laboratory result streams into the Health2Sync Patient Management Platform and routing flagged patients into monitoring workflows and clinical review queues for follow up.
Governance and rollout are organized through the MOU framework, aligning clinical protocols and data handling between AstraZeneca Taiwan and Health2Sync, and establishing clinical workflow touchpoints for provider adoption. The program explicitly frames the Health2Sync Patient Management Platform as a digital patient management layer for CKD early detection and ongoing monitoring within AstraZeneca Taiwan’s chronic disease management initiatives.
|
 |
Novo Nordisk Japan | Life Sciences | 1068 | $83M | Japan | Health2Sync | Health2Sync Patient Management Platform | Patient Management | 2019 | n/a |
In 2019, Novo Nordisk Japan implemented the Health2Sync Patient Management Platform in partnership with Health2Sync to support digital diabetes management in Japan. The Health2Sync Patient Management Platform is categorized as Patient Management and was localized and promoted by Novo Nordisk Pharma Ltd. following a December agreement announced in a March 5, 2019 press release from Taipei and Tokyo.
The implementation focused on the Health2Sync mobile App and companion web healthcare provider platform, delivering blood glucose trend analysis and treatment effectiveness tracking for clinicians and patients. The platform embeds a behavioral AI engine that provides contextual hints and nudges concerning meals, exercise, and blood glucose management, supporting patient engagement and adherence workflows common to Patient Management applications.
Operational coverage centered on enabling frequent digital touch points between people living with diabetes and their healthcare providers, bridging gaps between clinic visits. Deployment emphasized localized content and promotion for the Japanese market, with the platform used by doctors, patients, and Japanese healthcare providers to share data and insights through mobile and web channels.
Governance of the rollout was driven by the commercial partnership between Health2Sync and Novo Nordisk Pharma Ltd., aligning product localization, promotion, and provider outreach with Novo Nordisk’s patient centred business approach. The announced collaboration positioned the Health2Sync Patient Management Platform to deliver clinician facing trend visibility and patient facing engagement tools, and it was presented by both organizations as a capability to demonstrate shared value for the patient, the physician, and the Japanese healthcare provider.
|
 |
Sanofi KK Japan | Life Sciences | 1341 | $1.4B | Japan | Health2Sync | Health2Sync Patient Management Platform | Patient Management | 2022 | n/a |
In 2022, Sanofi KK Japan deployed the Health2Sync Patient Management Platform as a Patient Management application to deliver digitized insulin management support for patients and healthcare providers in Japan. The deployment reflects a partnering agreement with Health2Sync focused on clinical care and chronic disease management for insulin treated patients, and positions the Health2Sync Patient Management Platform as the operational hub for insulin titration workflows and patient monitoring.
The implementation centers on insulin titration and patient management capabilities, including use of connected caps for dose capture and titration alerts for patients and HCPs. Configuration work emphasized insulin titration logic, patient enrollment and remote monitoring workflows, and HCP-facing management screens to review dosing history and alert triage, consistent with Patient Management functional workflows.
Operational coverage is Japan, serving patients and healthcare professionals in clinical settings and outpatient diabetes care. Governance was established through the Sanofi and Health2Sync partnering agreement, aligning clinical protocols and titration thresholds with platform configuration and rollout decisions. The program explicitly targets improved insulin titration and glycemic control as primary clinical objectives.
|
 |
Sompo Holdings | Insurance | 80000 | $35.9B | Japan | Health2Sync | Health2Sync Patient Management Platform | Patient Management | 2022 | n/a |
In 2022, Sompo Holdings subsidiary Sompo Himawari Life integrated Health2Sync Patient Management Platform into its Linkx Blood Glucose Coaching service to visualize glucose trends and deliver lifestyle coaching and messages to insured customers. The deployment centers on the Health2Sync Patient Management Platform mobile client embedded in an insurer-led coaching workflow within Sompo Himawari Life, aligning the project with the Patient Management category and payer prevention and care management use cases in Japan.
The implementation configures core patient management capabilities, including glucose trend visualization, secure capture of user-consented biometric data, in-app messaging for lifestyle coaching, and clinician or coach-facing dashboards for monitoring adherence and risk indicators. Health2Sync Patient Management Platform functionality is applied to automate data ingestion from the mobile app, normalize time-series glucose records, and surface actionable trends to the insurer’s care teams, consistent with common Patient Management workflows.
Operational coverage is specific to Sompo Himawari Life’s Linkx/Blood Glucose Coaching program and targets insured members in Japan within payer prevention and care management. The platform is used to combine user-consented data with insurance-led health services and underwriting initiatives, enabling data flows between the mobile client, coaching operations, and insurer decisioning processes without naming additional third-party systems.
Governance and process changes emphasize consent management and data routing controls, with the insurer configuring workflows to ensure that patient-consented glucose data is partitioned for coaching use while enabling controlled access for underwriting and care management teams. The initiative focuses on embedding the Health2Sync Patient Management Platform into existing insurer workflows, restructuring coach notification and messaging processes to operationalize continuous glucose monitoring insights for insured populations.
|
Showing 1 to 4 of 4 entries
Buyer Intent: Companies Evaluating Health2Sync Patient Management Platform
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Health2Sync Patient Management Platform. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Health2Sync Patient Management Platform for Patient Management include:
- Korman Residential, a United States based Construction and Real Estate organization with 80 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated |
|---|---|---|---|---|---|---|
 |
Korman Residential | Construction and Real Estate | 80 | $8M | United States | 2024-10-03 |
FAQ - APPS RUN THE WORLD Health2Sync Patient Management Platform Coverage
Health2Sync Patient Management Platform is a Patient Management solution from Health2Sync.
Companies worldwide use Health2Sync Patient Management Platform, from small firms to large enterprises across 21+ industries.
Organizations such as AstraZeneca, Sompo Holdings, Sanofi KK Japan and Novo Nordisk Japan are recorded users of
Health2Sync Patient Management Platform for Patient Management.
Companies using Health2Sync Patient Management Platform are most concentrated in Life Sciences and Insurance, with adoption spanning over 21 industries.
Companies using Health2Sync Patient Management Platform are most concentrated in United Kingdom and Japan, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Health2Sync Patient Management Platform across Americas, EMEA, and APAC.
Companies using Health2Sync Patient Management Platform range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 50%, and global enterprises with 10,000+ employees - 50%.
Customers of Health2Sync Patient Management Platform include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Health2Sync Patient Management Platform customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Patient Management.